Enquiry@akums.net
9999012080
Pharmaceuticals
API
Nutraceuticals & Ayurvedic
Cosmetics & Dermatology
Contact Us
×
About Us
Business Model
Business Partner
Timeline
Our Expertise
Manufacturing
Innovation
Quality
Regulatory
Research & Development
Global Presence
EU-GMP
Knowledge Base
Blogs
Akums in News
Industry News
Careers
Gallery
Contact Us
☰
About Us
Pharmaceuticals
API
Nutraceuticals & Ayurvedic
Cosmetics & Dermatology
Our Expertise
Manufacturing
Innovation
Quality
Regulatory
Research & Development
Business Model
Business Partner
Timeline
Global Presence
EU-GMP
Knowledge Base
Blogs
Akums in News
Industry News
Careers
Gallery
Contact Us
Biospectrum's Magazine June 2023 Edition - Akums Launches a novel Combikit - Amoxicillin + Clarithromycin + Esomeprazole..
Read more
Biospectrum's Magazine June 2023 Edition - “More needs to be done to provide a conducive ecosystem for API manufacturing in India
Read more
Akums has been honored with "Best manufacturer for Innovation in Cosmetics and Wellness.
Read more
Financial Express (23rd May 2023) - How do the right manufacturers ensure contamination-free high-value non-oral drugs?
Read more
Medical Dialogues (22nd May 2023) - Akum Gets CDSCO Panel Nod to Manufacture, Market Glimepiride, Lobeglitazone FDC
Read more
Healthcare Radius ( 08th Feb 2023) – Akums Launches Type 2 Diabetes Drug, Lobeglitazone
Read more
Medical Dialogues ( 06th Feb 2023) – Akums Drugs and Pharma Bags DCGI Nod to Unveil Type 2.. Read More
Read more
Biospectrum India ( 06th Feb 2023) – Akums receives DCGI approval for type 2 diabetes drug to..
Read more
ET Healthworld ( 06th Feb 2023) – Akums gets DCGI nod to launch anti-diabetic drug Lobeglitazone..
Read more
Express Pharma ( 06th Feb 2023) – Akums gets DCGI approval to launch Lobeglitazone for diabetes..
Read more
1
2
3
…
20
>>
Solverwp- WordPress Theme and Plugin
→
9999012080
Enquiry@akums.net